Yukiko Iino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yukiko Iino has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Masayo Hasegawa
7 shared publicationsAkihiro Shinnabe
6 shared publicationsMariko Hara
Department of Otorhinolaryngology, Jichi Medical University Saitama Medical Center
5 shared publications- Naohiro Yoshida
Department of Otolaryngology‐Head and Neck Surgery Jichi Medical University Saitama Medical Center Saitama Japan
5 shared publications Shingo Matsuzawa
Department of Otorhinolaryngology, Jichi Medical University Saitama Medical Center
5 shared publicationsHiromi Kanazawa
Department of Otolaryngology, Jichi Medical University Saitama Medical Center, Saitama, Japan
4 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (4) , 633-638
Peripheral blood eosinophils as an adjunctive biomarker for eosinophilic otitis media: Supporting the validity of current diagnostic criteria
- 10 July 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (4) , 633-638
Open AccessPeripheral blood eosinophils as an adjunctive biomarker for eosinophilic otitis media: Supporting the validity of current diagnostic criteria
- 10 March 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (5) , 539-543
Surgical Results of Canalplasty Using a Pedicled Periosteal Flap for External Auditory Canal Cholesteatoma
Objective: We evaluated the outcomes of canalplasty for external auditory canal cholesteatoma (EACC) using an inferior-pedicled periosteal flap to cover the eradicated diseased bone. Study Design: Retrospective chart review. Setting: Tertiary referral center. Patients: Thirty-one ears in 30 patients surgically treated for stages III and IV primary EACC. Intervention: Canalplasty using an inferior-pedicled periosteal flap with or without tympanoplasty. Main Outcome Measures: Disease recurrence, hearing, and clinical factors influencing the time taken to achieve complete epithelization of the external auditory canal. Results: The 31 ears with EACC required 2 to 40 weeks (mean, 7.8 wk; median, 4 wk) to achieve complete epithelization. After epithelization, 84% of the ears became self-cleaning ear canals without any local treatment. Two patients with renal dysfunction experienced recurrence of EACC in the anterior-superior bony canal wall and needed additional treatment. Younger patients took a significantly shorter time to achieve epithelization than older patients (p < 0.001). Patients with renal dysfunction tended to need longer periods for epithelization than those without renal dysfunction (p = 0.092). Conclusion: Canalplasty for stages III and IV EACC using an inferior-pedicled periosteal flap achieved good postoperative results, with 86% of ears becoming self-cleaning ear canals in a short healing time. Special attention must be paid to the patients with renal dysfunction to create a pedicled flap of sufficient size to cover the bone and maintain a good blood supply.
- 10 March 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (5) , 539-543
Surgical Results of Canalplasty Using a Pedicled Periosteal Flap for External Auditory Canal Cholesteatoma
Objective: We evaluated the outcomes of canalplasty for external auditory canal cholesteatoma (EACC) using an inferior-pedicled periosteal flap to cover the eradicated diseased bone. Study Design: Retrospective chart review. Setting: Tertiary referral center. Patients: Thirty-one ears in 30 patients surgically treated for stages III and IV primary EACC. Intervention: Canalplasty using an inferior-pedicled periosteal flap with or without tympanoplasty. Main Outcome Measures: Disease recurrence, hearing, and clinical factors influencing the time taken to achieve complete epithelization of the external auditory canal. Results: The 31 ears with EACC required 2 to 40 weeks (mean, 7.8 wk; median, 4 wk) to achieve complete epithelization. After epithelization, 84% of the ears became self-cleaning ear canals without any local treatment. Two patients with renal dysfunction experienced recurrence of EACC in the anterior-superior bony canal wall and needed additional treatment. Younger patients took a significantly shorter time to achieve epithelization than older patients (p < 0.001). Patients with renal dysfunction tended to need longer periods for epithelization than those without renal dysfunction (p = 0.092). Conclusion: Canalplasty for stages III and IV EACC using an inferior-pedicled periosteal flap achieved good postoperative results, with 86% of ears becoming self-cleaning ear canals in a short healing time. Special attention must be paid to the patients with renal dysfunction to create a pedicled flap of sufficient size to cover the bone and maintain a good blood supply.
- Open Access
- 15 December 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 50 (4) , 479-489
Eosinophilic otitis media; state-of-the-art diagnosis and treatment
- 15 December 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 50 (4) , 479-489
Open AccessEosinophilic otitis media; state-of-the-art diagnosis and treatment
- 1 June 2021
- Published by Elsevier in Auris Nasus Larynx
- Vol. 48 (3) , 353-360
Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma
- 1 June 2021
- Published by Elsevier in Auris Nasus Larynx
- Vol. 48 (3) , 353-360
Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma
- 1 April 2019
- Published by Elsevier in Auris Nasus Larynx
- Vol. 46 (2) , 196-203
Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media
- 1 April 2019
- Published by Elsevier in Auris Nasus Larynx
- Vol. 46 (2) , 196-203
Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media
- 6 November 2015
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 15 (12) , 1-6
New Insights into Eosinophilic Otitis Media
Eosinophilic otitis media (EOM) is a type of intractable otitis media that occurs mainly in patients with bronchial asthma (BA). In 2011, the diagnostic criteria for EOM were established. EOM is characterized by the presence of a highly viscous yellowish effusion containing eosinophils and immunoglobulin E (IgE), eosinophil chemoattractants, such as eosinophil cationic protein, interleukin-5, and eotaxin. Local sensitization against foreign agents such as fungi or bacteria (e.g., Staphylococcus aureus) may result in local IgE production in the middle ear and may be responsible for the severity of EOM. The clinical features of EOM closely resemble localized eosinophilic granulomatosis polyangiitis, therefore it is necessary to be vigilant to the symptoms of mononeuritis, polyneuritis, and skin purpura during diagnosis. Standard treatment for EOM is the instillation of triamcinolone acetonide into the mesotympanum. However, severe cases exhibiting strong inflammation and otorrhea are not easily controlled with antibiotics and/or corticosteroids. We proposed the introduction of a severity score to evaluate the severity of EOM. This score correlated with local IgE levels in middle ear effusion. Clinically, the risk factors associated with this severity score were body mass index, and the duration of bronchial asthma (from the onset of BA to the age of the first consultation of otitis media to our hospital). We emphasize that early diagnosis and adequate treatment are vital in preventing progressive and sudden hearing loss resulting from EOM.
- 6 November 2015
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 15 (12) , 1-6
New Insights into Eosinophilic Otitis Media
Eosinophilic otitis media (EOM) is a type of intractable otitis media that occurs mainly in patients with bronchial asthma (BA). In 2011, the diagnostic criteria for EOM were established. EOM is characterized by the presence of a highly viscous yellowish effusion containing eosinophils and immunoglobulin E (IgE), eosinophil chemoattractants, such as eosinophil cationic protein, interleukin-5, and eotaxin. Local sensitization against foreign agents such as fungi or bacteria (e.g., Staphylococcus aureus) may result in local IgE production in the middle ear and may be responsible for the severity of EOM. The clinical features of EOM closely resemble localized eosinophilic granulomatosis polyangiitis, therefore it is necessary to be vigilant to the symptoms of mononeuritis, polyneuritis, and skin purpura during diagnosis. Standard treatment for EOM is the instillation of triamcinolone acetonide into the mesotympanum. However, severe cases exhibiting strong inflammation and otorrhea are not easily controlled with antibiotics and/or corticosteroids. We proposed the introduction of a severity score to evaluate the severity of EOM. This score correlated with local IgE levels in middle ear effusion. Clinically, the risk factors associated with this severity score were body mass index, and the duration of bronchial asthma (from the onset of BA to the age of the first consultation of otitis media to our hospital). We emphasize that early diagnosis and adequate treatment are vital in preventing progressive and sudden hearing loss resulting from EOM.
- 1 March 2015
- Vol. 94 (3) , 117-20
A case of solitary fibrous tumor arising from the palatine tonsil.
Solitary fibrous tumor (SFT) is a distinctive, relatively uncommon soft-tissue neoplasm that usually arises from the pleura. It occurs at various sites; head and neck lesions are very rare. While most of these tumors have a benign course, a small number have malignant potential. We describe a rare case of SFT arising from the left palatine tonsil in a 66-year-old Japanese woman. The mass was completely resected. Immunohistochemical studies were strongly positive for CD34 and bcl-2, mildly positive for phosphorylated protein kinase B and phosphorylated extracellular signal-regulated kinase 1/2, and negative for platelet-derived growth factor receptor alpha and p53. These findings suggested that this tumor was benign. The patient showed no evidence of recurrence during 2 years of follow-up. We believe that the candidate prognostic marker should be checked to distinguish malignant from benign SFTs.
- 1 March 2015
- Vol. 94 (3) , 117-20
A case of solitary fibrous tumor arising from the palatine tonsil.
Solitary fibrous tumor (SFT) is a distinctive, relatively uncommon soft-tissue neoplasm that usually arises from the pleura. It occurs at various sites; head and neck lesions are very rare. While most of these tumors have a benign course, a small number have malignant potential. We describe a rare case of SFT arising from the left palatine tonsil in a 66-year-old Japanese woman. The mass was completely resected. Immunohistochemical studies were strongly positive for CD34 and bcl-2, mildly positive for phosphorylated protein kinase B and phosphorylated extracellular signal-regulated kinase 1/2, and negative for platelet-derived growth factor receptor alpha and p53. These findings suggested that this tumor was benign. The patient showed no evidence of recurrence during 2 years of follow-up. We believe that the candidate prognostic marker should be checked to distinguish malignant from benign SFTs.
- 1 February 2015
- Vol. 64 (1) , 38-45
[Eosinophilic chronic rhinosinusitis].
- 26 January 2015
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 135 (3) , 217-225
Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media
Conclusion: Additional treatment with clarithromycin (CAM) reduced persistent middle ear inflammation after acute otitis media (AOM) caused by Haemophilus influenzae in children. CAM is a treatment option for persistent inflammation following AOM and to prevent continuing otitis media with effusion. Objective: We conducted a clinical study to evaluate a new method of treatment for persistent inflammation after AOM in children. Methods: H. influenzae-infected children with AOM were treated acutely with antimicrobial agents, after which those still demonstrating effusion of the middle ear cavity received additional treatment with carbocysteine (S-CMC) alone or S-CMC combined with clarithromycin (CAM) for 1 week. The two regimens were compared in terms of clinical effects. Results: After the initial acute treatment, many patients still showed abnormal otoscopic findings. At the completion of additional treatment, there were no significant differences between the two treatment groups. However, 1 week after completion of additional treatment, the prevalence of a diminished light reflex was significantly lower in the CAM + S-CMC group than in the S-CMC group (p = 0.017). The prevalence of redness of the tympanic membrane also tended to be lower in the combined treatment group than in those receiving a single drug (p = 0.097).
- 26 January 2015
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 135 (3) , 217-225
Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media
Conclusion: Additional treatment with clarithromycin (CAM) reduced persistent middle ear inflammation after acute otitis media (AOM) caused by Haemophilus influenzae in children. CAM is a treatment option for persistent inflammation following AOM and to prevent continuing otitis media with effusion. Objective: We conducted a clinical study to evaluate a new method of treatment for persistent inflammation after AOM in children. Methods: H. influenzae-infected children with AOM were treated acutely with antimicrobial agents, after which those still demonstrating effusion of the middle ear cavity received additional treatment with carbocysteine (S-CMC) alone or S-CMC combined with clarithromycin (CAM) for 1 week. The two regimens were compared in terms of clinical effects. Results: After the initial acute treatment, many patients still showed abnormal otoscopic findings. At the completion of additional treatment, there were no significant differences between the two treatment groups. However, 1 week after completion of additional treatment, the prevalence of a diminished light reflex was significantly lower in the CAM + S-CMC group than in the S-CMC group (p = 0.017). The prevalence of redness of the tympanic membrane also tended to be lower in the combined treatment group than in those receiving a single drug (p = 0.097).
- 1 January 2015
- Published by The Society of Practical Otolaryngology in Practica oto-rhino-laryngologica. Suppl.
- Vol. 141, 56-57
Five Cases of IgG4-related Diseases
- 1 January 2015
- Published by The Society of Practical Otolaryngology in Practica oto-rhino-laryngologica. Suppl.
- Vol. 141, 56-57
Five Cases of IgG4-related Diseases